MORGAN STANLEY

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 895421 NEW YORK, NY

Back to ARQT Full portfolio

Position in ARQT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$99,398,010

-$26,642,527 QoQ

Shares Held

4,218,931

-2.8% QoQ

Ownership

3.37%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 95.68724873670605.ToString("F0")% Shared 0.ToString("F0")% None 4.312751263293948.ToString("F0")%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. ARQT ranks #31 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

All Filings in ARQT

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$99,398,010	4,218,931	-2.8%	Shares	Defined	2026-05-15
2025-12-31	$126,040,537	4,340,239	+1.5%	Shares	Defined	2026-05-27
2025-09-30	$80,610,024	4,276,394	-0.9%	Shares	Defined	2026-05-27
2025-06-30	$60,489,708	4,314,530	+12.4%	Shares	Defined	2025-08-15
2025-03-31	$60,034,778	3,838,541	-9.6%	Shares	Defined	2025-05-15
2024-12-31	$59,117,676	4,243,911	+12.2%	Shares	Defined	2025-05-15
2024-09-30	$35,165,110	3,781,195	-4.8%	Shares	Defined	2025-05-14
2024-06-30	$36,946,050	3,972,694	-0.8%	Shares	Defined	2025-05-14
2024-03-31	$39,702,774	4,006,335	-34.1%	Shares	Defined	2024-10-17
2023-12-31	$19,648,319	6,083,072	+2639.6%	Shares	Defined	2024-08-16
2023-09-30	$1,179,030	222,040	-54.3%	Shares	Defined	2023-11-15
2023-06-30	$4,631,368	485,978	+43.9%	Shares	Defined	2023-08-14
2023-03-31	$3,714,194	337,654	+70.5%	Shares	Defined	2023-05-15
2022-12-31	$2,931,345	198,064	+58.5%	Shares	Defined	2023-02-14
2022-09-30	$2,387,331	124,926	+15.5%	Shares	Defined	2022-11-14
2022-06-30	$2,305,076	108,169	+11.0%	Shares	Defined	2022-10-27
2022-03-31	$1,876,922	97,452	+83.8%	Shares	Defined	2022-10-27
2021-12-31	$1,099,610	53,019	-63.1%	Shares	Defined	2022-02-14
2021-09-30	$3,434,088	143,746	-36.6%	Shares	Defined	2021-11-15
2021-06-30	$6,185,903	226,673	+80.3%	Shares	Defined	2021-08-23
2021-03-31	$3,636,846	125,712	-17.3%	Shares	Defined	2021-05-17
2020-12-31	$4,276,040	152,010	+5323.1%	Shares	Defined	2021-02-16
2020-09-30	$82,127	2,803	-21.6%	Shares	Defined	2020-11-13
2020-06-30	$108,046	3,573	+148.6%	Shares	Defined	2020-08-14
2020-03-31	$42,822	1,437	—	Shares	Defined	2020-05-26
No filing history on record for this holder in this stock.